Yale University

Publications

Filters: Author is Egan, James E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Elsesser, Steven A., Catherine E. Oldenburg, Katie B. Biello, Matthew J. Mimiaga, Steven A. Safren, James E. Egan, David S. Novak, Douglas S. Krakower, Ron Stall, and Kenneth H. Mayer. "Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM)." AIDS and behavior (2015). Abstract
Elsesser, Steven A., Catherine E. Oldenburg, Katie B. Biello, Matthew J. Mimiaga, Steven A. Safren, James E. Egan, David S. Novak, Douglas S. Krakower, Ron Stall, and Kenneth H. Mayer. "Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM)." AIDS and behavior (2015). Abstract
P
Egan, James E., Paul Casadonte, Tracy Gartenmann, Judith Martin, Elinore F. McCance-Katz, Julie Netherland, John A. Renner, Linda Weiss, Andrew J. Saxon, and David A. Fiellin. "The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment." Journal of general internal medicine 25, no. 9 (2010): 936-41. Abstract
Chaudhry, Amina A., Michael Botsko, Linda Weiss, James E. Egan, Jennifer Mitty, Barbara Estrada, Gregory M. Lucas, Tanita Woodson, Timothy P. Flanigan, and David A. Fiellin. "Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S14-21. Abstract
O
Lum, Paula J., Sherri Little, Michael Botsko, David Hersh, Robert E. Thawley, James E. Egan, Jennifer Mitty, Joshua Boverman, and David A. Fiellin. "Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S91-7. Abstract
I
Weiss, Linda, Julie Netherland, James E. Egan, Timothy P. Flanigan, David A. Fiellin, Ruth Finkelstein, and Frederick L. Altice. "Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S68-75. Abstract
Korthuis, Todd P., Mary Jo Tozzi, Vijay Nandi, David A. Fiellin, Linda Weiss, James E. Egan, Michael Botsko, Angela Acosta, Marc N. Gourevitch, David Hersh et al. "Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S39-45. Abstract
H
Vergara-Rodriguez, Pamela, Mary Jo Tozzi, Michael Botsko, Vijay Nandi, Frederick Altice, James E. Egan, Patrick G. O'Connor, Lynn E. Sullivan, and David A. Fiellin. "Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S62-7. Abstract
F
Netherland, Julie, Michael Botsko, James E. Egan, Andrew J. Saxon, Chinazo O. Cunningham, Ruth Finkelstein, Mark N. Gourevitch, John A. Renner, Nancy Sohler, Lynn E. Sullivan et al. "Factors affecting willingness to provide buprenorphine treatment." Journal of substance abuse treatment 36, no. 3 (2009): 244-51. Abstract
D
Fiellin, David A., Linda Weiss, Michael Botsko, James E. Egan, Frederick L. Altice, Lauri B. Bazerman, Amina Chaudhry, Chinazo O. Cunningham, Marc N. Gourevitch, Paula J. Lum et al. "Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S33-8. Abstract
C
Schackman, Bruce R., Jared A. Leff, Michael Botsko, David A. Fiellin, Fredrick L. Altice, Todd P. Korthuis, Nancy Sohler, Linda Weiss, James E. Egan, Julie Netherland et al. "The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S76-82. Abstract
B
Weiss, Linda, James E. Egan, Michael Botsko, Julie Netherland, David A. Fiellin, and Ruth Finkelstein. "The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S7-13. Abstract